ArticlePloS one2017

Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.

Michiko Narita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.